AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06705127 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: Local radiotherapy: Subjects received stereotactic radiotherapy for the primary breast cancer lesion at 8Gy each time for 3 consecutive days, once a day, 2 weeks before the start of systemic therapy
Study NCT06704789 — intervention group
Intervention type: DEVICE
Intervention: Measurement of brain activity (fNIRS, EEG)
Description: Brain activity assessments are conducted as a single session lasting approximately 60 minutes
Study NCT06706297 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pranayama breathing exercise
Description: Normal breathing, focusing on breathing, Alternative Nose Breathing, Cooling Breath, Bee Buzzing Sound, A breathing exercise of 20 minutes in total, consisting of 5 stages: normal breathing and focusing on breathing.
Study NCT06705777 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Combinations
Description: Aesculus hippocastanum, Polygonum acre, Smilax Pepyracea, and Rutin combination
Study NCT06705335 — intervention group
Intervention type: OTHER
Intervention: Blood sample
Description: On the same day as the tumour sample is taken (biopsy or surgery), a blood sample of approximately 15 to 20 mL is taken in EDTA-free tubes.
Study NCT06705296 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Open Label Deep Brain Stimulation
Description: Patients will receive open label deep brain stimulation
Study NCT06705296 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Double blinded Deep Brain Stimulation
Description: Patients will receive double blinded deep brain stimulation
Study NCT06705296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Description: Patients will receive prolonged exposure therapy
Study NCT06705296 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed loop Deep brain stimulation
Description: Patients will receive closed loop deep brain stimulation
Study NCT06704490 — intervention group
Intervention type: OTHER
Intervention: Cesarean section
Description: Observational study without intervention
Study NCT06706089 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led educational intervention
Description: This nurse-led educational intervention included: a) an oral training session regarding glaucoma by the P.I. lasting 15 minutes, b) provision of printed informational material (leaflet) and c) provision of appropriately selected free informational videos from the World Glaucoma Association on the YouTube -online platform. All of the above mentioned educational methods focused on the disease, its treatment and its long-term management. The oral training session took place in an appropriate, quiet and clean area, respecting the patient's privacy. During this process, study participants had the opportunity and time to ask questions and ask for clarifications or additional information.
Study NCT06706713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEBT-109 Capsule
Description: Take orally before breakfast and dinner each day, with a minimum interval of 9 hours between doses, 120mg each time, twice a day,and 28 days as a treatment cycle.
Study NCT06706635 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Application of App
Description: Full Access to Mobile App
Study NCT06706635 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Application of App
Description: Full Access to Mobile App
Study NCT06704984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Name: WeChat Intervention Based on the IMB Model
Description: A six-week intervention leveraging an online WeChat public account was implemented, integrating the IMB (Information-Motivation-Behavioral Skills) model into its design. Drawing from literature analysis, the intervention plan was structured into three distinct modules: information, motivation, and behavioral skills. The comprehensive intervention encompassed disseminating knowledge on Internet addiction, identifying and avoiding triggers, fostering withdrawal motivation, imparting coping strategies for cravings and challenging situations, enhancing self-efficacy, and facilitating access to personal and social support. Participants who followed the WeChat public account received automated push notifications containing articles or videos every two days. Throughout the intervention period, engagement was monitored by tracking the readership of the sent content through the WeChat public account's backend data.
Study NCT04965623 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atrial Shunt
Description: Transcatheter treatment of symptomatic left heart failure patients
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given oral (PO).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Navitoclax
Description: Given oral (PO).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given orally (PO) or intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine
Description: Given intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase Pegol
Description: Given intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Given oral (PO).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given intravenously (IV) or Intrathecal (IT).
Study NCT05192889 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Description: Given intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Given intravenously (IV), oral (PO), or Intrathecal (IT).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mercaptopurine
Description: Given oral (PO).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Given oral (PO) or intravenously (IV).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intrathecal Triples
Description: Given Intrathecal (IT).
Study NCT06016959 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietetic intervention
Description: Dietetic intervention involves individualised and tailored dietary advice to patients struggling with their nutrition. This includes optimising energy and protein intake to improve malnutrition \& also giving dietary advice to support with nutrition impact symptoms e.g. bloating.
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegaspargase
Description: May be used in place of Calaspargase Pegol where available. Given intravenously (IV) or intramuscularly (IM).
Study NCT05192889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erwinia asparaginase
Description: To be used in case of hypersensitivity or intolerance to Calaspargase Pegol or Pegaspargase. Given intravenously (IV) or intramuscularly (IM).
Study NCT05192889 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: See detailed description section.
Study NCT06280924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supported Exercise
Description: Participants will take part in a prehabilitation exercise program prior to undergoing a stem cell transplant.
Study NCT06280924 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Participants will receive standard care
Study NCT04745364 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A 4-week Bharatanatyam course from the organization Mindful Kala
Description: The 4-week Mindful Kala program focuses on three components of Bharatanatyam: nritta (i.e. technical movements), natya (i.e. storytelling), and nritya (i.e. a combination of movements and narration; nritta + natya).
Study NCT06219889 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Frequency of neurochecks
Description: the frequency with which a patient is awakened to perform serial examinations
Study NCT06219889 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Frequency of neurochecks
Description: the frequency with which a patient is awakened to perform serial examinations
Study NCT05734027 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sectional matrix
Description: The sectional matrix is the best way to achieve a strong contact point in Class II restorations with composite resin in the posterior dental sector. The pre-wedging is essential to get a separation between teeth which avoid the matrix deformation during its insertion
Study NCT05734027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sectional matrix
Description: The sectional matrix is the best way to achieve a strong contact point in Class II restorations with composite resin in the posterior dental sector. The pre-wedging is essential to get a separation between teeth which avoid the matrix deformation during its insertion
Study NCT05734027 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Circumferential matrix
Description: Circumferential matrix (thickness 0.038mm) ,the band encircle the tooth and secured by retainer on the buccal and lingual aspect
Study NCT05734027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Circumferential matrix
Description: Circumferential matrix (thickness 0.038mm) ,the band encircle the tooth and secured by retainer on the buccal and lingual aspect
Study NCT05383469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Training
Description: Endurance training with a resistance-free bicycle ergometer Strength training with bodyweight Non-resistance ankle pumping exercises
Study NCT05383469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage
Description: Classical massage including superficial and deep stroking and friction methods for the lower extremity.
Study NCT05383469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation
Description: Symmetrical biphasic current at a frequency of 30-85 Hz
Study NCT05383469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compression Therapy
Description: Compression therapy is a treatment applied to patients in the form of Four Layer Compression Bandage and Compression Stocking. Four Layer Compression Bandage is a treatment that requires four different types of bandages. The compression stocking is an elastic stock with various tension and length.
Study NCT05383469 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Compression Therapy
Description: Compression therapy is a treatment applied to patients in the form of Four Layer Compression Bandage and Compression Stocking. Four Layer Compression Bandage is a treatment that requires four different types of bandages. The compression stocking is an elastic stock with various tension and length.
Study NCT06024941 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiation to one or more progressive lesions. Preferably 1x10Gy, but also 3x8Gy, 10x 3Gy, 5x4Gy or 1x20-24Gy is possible.
Study NCT06377176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage therapy
Description: the intervention group underwent ten sessions of twice-weekly mother and infant massage therapy for five weeks.
Study NCT06016959 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Diet sheet (placebo)
Description: Patients randomised into the group receiving a diet sheet will be sent out Royal Brompton \& Harefield Hospital's Poor Appetite diet booklet which involves general strategies to improve nutritional status (energy and protein)
Study NCT06409806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ECOG Array
Description: The patient will undergo their intracranial neurosurgical procedure as planned, using conventional brain retractors and neurosurgical equipment.~Standard neuromonitoring (EEG, MEP, SSEP) will be placed after the induction of neuroanaesthesia if indicated. Additional to whatever conventional EMBRI neuromonitoring is used, intraoperatively an ECoG array will be positioned under the retractor by the operating surgeon. Further electrode arrays may be placed on the cortical surface remote from the retractor as needed to establish a reference.~Typically we anticipate one ECoG array under the retractor blade with a reference array on an area of unretracted brain.
Study NCT05979493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacain
Description: 30cc IM injection in each quadratus lumborum muscle (60cc total).
Study NCT05979493 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: 30cc IM injection in each quadratus lumborum muscle (60cc total).
Study NCT04803318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
Description: Oral administration of three inhibitors including Trametinib, Everolimus and Lenvatinib.
Study NCT05119777 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HArmonyCa Injectable Gel
Description: Subdermal or deep dermal injection
Study NCT06453148 — intervention group
Intervention type: OTHER
Intervention: Non-interventions
Description: Usual care evaluations
Study NCT05443308 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cerebral [15O]H2O PET before and after diamox infusion
Description: Cerebral \[15O\]H2O PET before and after diamox infusion
Study NCT05132153 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Milrinone
Description: will be given by nebulization
Study NCT05132153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: will be given by nebuliztion
Study NCT05136586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback
Description: 6 minutes of relaxing breathing exercise coupled with hert rate variability biofeedback guided on eMWave Pro software on a computer just before entering the examination circuit.~After the circuit, 6 minutes of free activity where the participants will not be given any instruction.
Study NCT05136586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meditation
Description: 6 minutes of listening an audio tape made for the study that inspire mindfulness like meditation associated with psychological stimulation (positive encouragement) just before entering the examination circuit.~After the circuit, 6 minutes of free activity where the participants will not be given any instructions.
Study NCT05136586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control and biofeedback post OSCE
Description: 6 minutes of standardised neutral video on general topics that generates no modification of affects just before entering the examination circuit.~After the circuit, 6 minutes of relaxing breathing exercise coupled with hert rate variability biofeedback guided on eMWave Pro software on a computer
Study NCT05136586 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control and control post OSCE
Description: 6 minutes of standardised neutral video on general topics that generates no modification of affects just before entering the examination circuit.~After the circuit, 6 minutes of of free activity where the participants will not be given any instruction.
Study NCT06296147 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: The interventions are for supportive care ONLY.
Study NCT06296147 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aromatherapy Patch
Description: The interventions are for supportive care ONLY.
Study NCT06296147 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care
Description: Participant will undergo a transperineal prostate biopsy.
Study NCT06296147 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Participant will undergo a transperineal prostate biopsy.
Study NCT05195164 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There was no intervention
Study NCT06117930 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT05119647 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thrombus Aspiration Catheter(Ton-bridgeMT)
Description: Thrombus Aspiration Catheter is a developed technique for treating acute stroke caused by artery occlusion. The catheter(Ton-bridgeMT) was specially designed for those patients who experience acute stroke within 24 hours.
Study NCT05387083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Dose TP-05
Description: Healthy Volunteers will receive a single low dose of TP-05 on Day 1.
Study NCT05387083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High Dose TP-05
Description: Healthy Volunteers will receive a single high dose of TP-05 on Day 1.
Study NCT05387083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Healthy Volunteers will receive a single dose of placebo on Day 1.
Study NCT05750251 — intervention group
Intervention type: PROCEDURE
Intervention: levator muscle resection surgery
Description: conventional ptosis surgery
Study NCT05750251 — intervention group
Intervention type: PROCEDURE
Intervention: Müller's muscle-conjuctival resection surgery
Description: conventional ptosis surgery
Study NCT05750251 — intervention group
Intervention type: PROCEDURE
Intervention: full-thickness anterior blepharotomy surgery
Description: conventional eyelid retraction surgery
Study NCT05306925 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Arginine
Description: The intervention infants will receive either parenteral nutrition which contains additional arginine (up to 18% arginine content) or a separate arginine infusion to provide up to 18% arginine. This is in comparison to standard parenteral nutrition which has an arginine content of 6.3%.
Study NCT02988297 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RNS60
Description: Nebulized RNS60 will be administered by daily inhalation for 24 weeks.
Study NCT02988297 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nebulized Placebo will be administered by daily inhalation for 24 weeks.
Study NCT05045768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Gelsectan, Devintec Sagl)
Description: Patients included in the study will receive for 28 days a capsule containing Xyloglucan, Pea Protein and Grape Seed Extract and a prebiotic Xylo-oligosaccharide (Gelsectan, Devintec sagl) twice daily.
Study NCT05830058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood collection
Study NCT05830058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study NCT05830058 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT05830058 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05830058 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT05661682 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tralement
Description: Tralement with Manganese Sulfate
Study NCT05661682 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fixed-dose trace element combination product of zinc, copper, and selenious acid
Description: Tralement without Manganese Sulfate
Study NCT06435936 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single Ascending Dose of SAB-176
Description: Single ascending dose
Study NCT06435936 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Single Ascending Dose of Placebo
Description: Single ascending dose
Study NCT06288581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional toothbrush group
Description: Children in this group will use a traditional brush with a traditional toothpaste first to clean their teeth then after 30 days they will use a U shaped brush with a traditional toothpaste for another 30 days.
Study NCT06288581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: U shaped toothbrush group
Description: Children in this group will use a U shaped brush with a traditional toothpaste first to clean their teeth then after 30 days they will use a traditional brush with a traditional toothpaste for another 30 days.
Study NCT06104228 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 129Xe Hyperpolarized
Description: Each xenon dose will be limited to a volume less than 25% of a subject's total lung capacity (TLC), as is the case for all protocols currently carried out under IND 109490